Abu Dhabi: AI Aids In Identifying At-Risk Cancer Individuals, Drug Development


(MENAFN- Khaleej Times) Published: Wed 15 May 2024, 6:55 PM

Artificial intelligence, particularly machine learning, stands as a powerful ally in cancer care, a medical expert said during the Abu Dhabi Global Healthcare Week.

Dr Faek El Jamali, staff physician, colorectal surgeon, Digestive Disease Institute at Cleveland Clinic Abu Dhabi (CCAD), noted that AI contributes to the detection and prevention of cancer.


“AI accelerates drug discovery by deciphering the complexities of protein structures, vital for developing targeted therapies. AI aids in identifying at-risk individuals through a comprehensive analysis of health
records, enabling clinic
ians to personalise prevention strategies. By leveraging AI's predictive capabilities, we can proactively address potential cancer risks and optimise preventive measures,” Dr Jamali, who was also the chair of the Cleveland Clinic Global Summit on innovations in cancer, told Khaleej Times.

Dr Faek El Jamali. Photo: Supplied

Dr Jamali noted that cancer is fundamentally a genetic disease
, where errors occur at the genetic level within the cancer cells themselves.


Stay up to date with the latest news. Follow KT on WhatsApp Channels.

“Genetic testing becomes pivotal in two scenarios. Firstly, it helps identify inherited patterns of cancer within families, guiding tailored treatment
s and management strategies. Secondly, genetic testing aids in prevention efforts, particularly at a population level. Emerging blood tests hold promise for early cancer screening, potentially revolutionising routine check-ups by providing insights into individual cancer risks.”

Talking about the latest developments in cancer prediction and detection, Dr Jamali underlined that there has been a paradigm shift from cancer diagnosis through external observations to molecular-based classifications, which focuses on the genetic makeup of cancers.

Dr Jamali added: "This precision approach allows for tailored treatment
s that specifically target cancer-causing mutations, sparing health
y cells. Additionally, advancements in immunotherapy and understanding the body's immune response further enhance cancer treatment
strategies. Integrating these modalities marks a transformative era in cancer therapy, driving towards precision medicine
and improved patient outcomes.”

ALSO READ:

  • Abu Dhabi: TB screening to be automated, ease visa application process
  • Doctor in UAE, treatment
    7,000km away in Korea: World's first public telerobotic surgery trial performed for stroke

MENAFN15052024000049011007ID1108218476


Khaleej Times

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.